HR 9347 United States House · 118th Congress

STOP TRANQ Act

The STOP TRANQ Act requires the U.S. government to include xylazine - a veterinary sedative increasingly mixed with illicit drugs - in the annual International Narcotics Control Strategy Report. This amendment adds xylazine to the list of substances tracked alongside illicit fentanyl, improving data collection on its role in drug trafficking and public health threats. The bill focuses on standardizing international reporting to better assess global drug trends, without altering enforcement or funding. It directly affects the Department of State and the Office of National Drug Control Policy, which produce the report.
Bill status in committee 1 of 4 stages cleared
Introduction
Aug 2024
Committee Review
Floor Vote
President
Introduced Aug 13, 2024 Last action Aug 13, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Aug 13, 2024
Committee
Referred to the House Committee on Foreign Affairs.
lower
Aug 13, 2024
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors

Sponsors